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Disseminated infection with organisms of the Mycobacterium avium complex (MAC) is a common compli-
cation of AIDS in the United States and other developing countries, but it is rare or absent in sub-Saharan
Africa. To assess the comparative likelihood of exposure to MAC in these geographic areas, we used a standard
protocol to culture 91 water samples from environmental sites and piped water supply systems in the United
States, Finland, Zaire, and Kenya. MAC was isolated from all geographic areas and from 22 of 91 (24%)
samples. Isolation rates were 13 of 47 (28%) for environmental samples and 9 of 44 (20%o) for water supply
samples. Overall isolation rates were 18 of 52 (35%) samples in the United States and Finland, whereas they
were 4 of 39 (10%Yo) samples in Zaire and Kenya (P = 0.015). MAC isolation rates from water supply systems
were 8 of 25 (32%) samples in the United States and Finland and 1 of 19 (5%) samples in Zaire and Kenya (P
= 0.056). MAC was isolated from hospital water in the United States and Finland but not in hospital water in
Zaire and Kenya. Serovar determinations showed that six of eight isolates from the United States were serovar
4 or 8. One MAC isolate from Zaire was identified as an "X" mycobacterium. These data suggest that exposure
to MAC in water is likely in diverse areas of the world, but that the likelihood of human exposure to the
organism in water may be slightly less in sub-Saharan Africa than in developed countries in the Northern
Hemisphere.
Organisms of the Mycobacterium avium complex (MAC)
are environmental mycobacteria which cause disseminated
infection in as many as 20 to 40% of patients with late-stage
AIDS in the United States and other developed countries
(11, 14, 18, 19). MAC can be isolated from numerous sources
in the environment, including water, aerosols, soil, mud, and
plants (7). Although the specific environmental source of
most MAC infections in patients with AIDS is not known,
water or water aerosols are a leading possibility (11). Expo-
sure to water is common enough to explain a disease which
affects as many as 40% of people with AIDS. In addition,
nosocomial common source outbreaks of other nontubercu-
lous mycobacteria have been traced to contaminated water
(1-3, 16).
Although studies from various parts of the world have
shown the widespread distribution of environmental MAC
isolates, disseminated MAC infection has not been found in
clinical and autopsy studies of patients with AIDS in Africa
(17, 24). This observation could be explained by variations in
the environmental distribution of MAC, differences in be-
haviors which result in exposure to MAC, or differences in
host resistance to MAC. We examined these issues in an
international epidemiologic study of disseminated MAC in-
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fection in patients with AIDS at five geographically diverse
sites chosen to represent areas where the prevalence of
disseminated MAC in patients with AIDS was expected to
be high (United States [two sites], Finland) or low (Kenya,
Zaire). In this report we describe the results for cultures of
water samples obtained from these same five sites to assess
the relative likelihood of human exposure to MAC in each of
these areas.
(The study described here was presented in part at the
93rd General Meeting of the American Society for Microbi-
ology, Atlanta, Ga., 16 to 20 May 1993 [6a].)
MATERIALS AND METHODS
Collection ofwater samples. Water samples were collected
from numerous environmental sites (including rivers,
streams, lakes, ponds, harbors, marshes, and standing wa-
ter) as well as from piped water supply systems (including
piped municipal and private drinking water supplies) from
March 1990 through February 1992. Samples were collected
in sterile 250-ml wide-mouth plastic bottles at ambient tem-
perature during one or more different months (New Hamp-
shire, February and March; Boston, February, August, and
October; Finland, February, May, and July; Kenya, January
and April; Zaire, December). Bottles were either dipped into
the water (for most environmental samples) or filled from a
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tap. In most cases the bottles were filled completely; the
minimum volume collected was 100 ml per sample. Bottles
were sealed with Parafilm (American National Can, Green-
wich, Conn.), capped, and shipped to Virginia for process-
ing. All samples were processed within 5 weeks of collec-
tion.
Processing of water samples. Twenty-five-milliliter water
samples were centrifuged at 5,000 x g for 30 min at 22°C in
sterile, 50-ml screw-cap centrifuge tubes. The supernatant
was decanted and its pH was measured. The pellet was
suspended in 1 ml of sterile distilled water by vortexing, and
0.1 ml (in triplicate) of the liquid was spread to dryness onto
Tsukamura minimal-Tween 80-cycloheximide agar medium
plates (8) containing 0.073 M KH2PO4, 0.002 M MgSO4.
7H20, 0.02 M (NH4)2SO4, 1% (vol/vol) Tween 80 (Sigma
Chemical Co., St. Louis, Mo.), and 1.5% agar (BBL Micro-
biology Systems, Cockeysville, Md.). The pH of the medium
was adjusted to 5.5 with KOH, and the medium was steril-
ized by autoclaving. To prevent fungal growth, cyclohexim-
ide (Sigma Chemical Co.) at 500 mg/liter was added to cooled
sterile medium before medium was poured into the plates.
After the liquid was spread, the plates were sealed with
Parafilm (American National Can) and were incubated at
37°C in air. Colony formation was observed daily for up to 60
days.
Identification of organisms. Colonies of different morphol-
ogies were stained by the Ziehl-Neelsen method, and acid-
fast colonies of the same morphology were counted. Repre-
sentatives of each colony type were streaked on
Lowenstein-Jensen slants or Middlebrook 7H10 agar plates,
and the slants and plates were incubated at 37°C in air.
Growth, as judged by the appearance of colonies, was
followed daily for up to 60 days. Rapidly growing mycobac-
teria (i.e., growth within 7 days) were discarded. Slowly
growing mycobacteria (i.e., growth after more than 7 days)
were kept for identification. Pigmentation was noted, and
isolates were grown in 10 ml of Middlebrook 7H9 broth for
serotyping and identification by DNA probe analysis and
were streaked onto Middlebrook 7H10 agar medium plates
to ensure pure cultures. Putative MAC isolates were identi-
fied by using DNA probes, and organisms which hybridized
with the MAC probes were then tested with probes to
distinguish M. avium from Mycobacterium intracellulare
and "X"' mycobacterium (SNAP DNA Probe; Digene Diag-
nostics Inc., Silver Spring, Md., or Gen-Probe, San Diego,
Calif.). Selected MAC isolates were serotyped by the State
Health Laboratory, Queensland Department of Health, Bris-
bane, Queensland, Australia (5).
RESULTS
MAC isolates were recovered from water samples col-
lected at each of the five geographic locations and were
recovered as frequently from piped water supply systems as
from environmental sites (Table 1). Isolation rates were
higher from samples collected in developed countries than
from those collected in developing countries: 18 of 52 (35%)
samples from the United States and Finland compared with
4 of 39 (10%) samples from Zaire and Kenya (P = 0.015).
Concentrations of MAC in water samples positive for MAC
ranged from 0.2 to 1,000 CFU/ml; median concentrations
were 0.4 to 40 CFU/ml at the five sites and did not differ
among the geographic sites. Two environmental sources
yielded 1,000 CFU of MAC per ml: the Charles River in
Boston and lake water from a bucket in a Finnish sauna.
MAC was isolated during 6 of the 8 months when samples
TABLE 1. Recovery of MAC from water by geographic site
and source of sample
No. of MAC-positive samples/no. of samples (%)
Site
Environmental' Water supplyb Total
New Hampshire 2/6 (33) 1/6 (17) 3/12 (25)
Boston 5/13 (38) 2/8 (25) 7/21 (33)
Finland 3/8 (37) 5/11 (45) 8/19 (42)
Zaire 1/3 (33) 1/5 (20) 2/8 (25)
Kenyac 2/17 (12) 0/14 (0) 2/31 (6)
Total 13/47 (28) 9/44 (20) 22/91 (24)
a Environmental samples were collected from rivers, streams, lakes, ponds,
harbors, marshes, and standing water.
b Water supply samples were collected from wells, hot and cold municipal
water supplies, showers, and standpipes.
c Includes five water samples collected from northern Tanzania.
were collected (exceptions were May in Finland and Febru-
ary in New Hampshire).
Among samples collected from water supply systems,
MAC isolation rates were 8 of 25 (32%) samples from
developed countries (New Hampshire, Boston, and Finland)
and 1 of 19 (5%) samples from developing countries (Kenya
and Zaire) (P = 0.056; Fisher's exact test). MAC was not
isolated from water supply systems in Kenya. MAC could be
recovered from hospital water supplies in the United States
and Finland but not from hospital water supplies in Kenya
and Zaire (Table 2). Among water supply systems, MAC was
isolated from both hot water (4 of 14 [29%] samples) and cold
water (5 of 30 [17%] samples) (P = 0.61). Five water supply
samples (all culture negative) were collected from wells; the
remaining 39 samples were collected from municipal chlori-
nated water systems (chlorine levels were not measured).
Pipes for municipal water supplies were made from a variety
of materials, including cement, iron, and plastic. Pipes in
hospital water systems were also constructed from a variety
of materials; galvanized pipes were used only in the two
Finnish hospitals (for cold water).
Among samples collected from the environment, MAC
isolation rates were not significantly different in developed
(10 of 27 [37%] samples) and developing (3 of 20 [15%]
samples) countries (P = 0.18). MAC was isolated more
frequently from rivers and streams (7 of 12 [58%] samples)
than from lakes and ponds (2 of 16 [12%] samples) (P =
0.017; Fisher's exact test). Most water samples had pH
values from 6.0 to 7.9; MAC isolation rates were not related
to pH within this narrow range.
MAC was isolated from water samples that were pro-
cessed as long as 5 weeks after collection, including one set
TABLE 2. Recovery of MAC from water collected from patient
care facilities (clinics and hospitals)
No. of MAC-positive samples/no. of
Site samples (%)
Hot water Cold water Total
New Hampshire 1/2 (50) 0/2 (0) 1/4 (25)
Boston 1/3 (33) 0/4 (0) 1/7 (14)
Finland 2/5 (40) 3/5 (60) 5/10 (50)
Zaire 0/1 (0) 0/2 (0) 0/3 (0)
Kenya 0/2 (0) 0/4 (0) 0/6 (0)
Total 4/13 (31) 3/17 (18) 7/30 (23)
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of water samples collected in Finland in which six of eight
samples were positive for MAC. MAC isolation rates did not
differ by interval from the time of collection to processing, as
follows: <1 week, 7 of 25 (28%) samples; 2 weeks, 5 of 32
(16%) samples; 3 weeks, 0 of 4 (0%) samples; 4 weeks, 2 of
8 (25%) samples; 5 weeks, 8 of 22 (36%) samples.
The 22 positive samples yielded 29 MAC isolates with
distinct colonial morphologies. Species probes were per-
formed on 24 isolates; 23 were M. avium and one was an
"X" mycobacterium. The serovars of eight M. avium iso-
lates from four samples collected in New Hampshire and
Boston were determined, with the following results: serovar
4, two isolates; serovar 8, four isolates; multiple serovars,
one isolate; and nontypeable, one isolate. One MAC isolate
from Zaire was identified as an "X" mycobacterium (4).
DISCUSSION
Previous environmental surveys have documented the
presence of MAC in water and other environmental samples
from both Africa and the United States (7, 10, 17, 20), but
this is the first study to compare by similar methods rates of
isolation of MAC from diverse geographic sites in both
developed and developing countries. Overall MAC isolation
rates were higher in developed countries than in developing
countries, principally because of higher isolation rates from
piped water supply systems. The use of water for drinking
and bathing (piped water supply systems in the present
study) is more likely than the use of water present in rivers,
lakes, and other environmental sources to result in exposure
of adults to MAC. Thus, the higher rates of isolation of MAC
from water supply systems in the United States and Finland
compared with those from water supply systems in Kenya
and Zaire are especially significant; many patients with
late-stage AIDS in developed countries have been hospital-
ized and exposed to hospital water. Other studies have
documented the presence of MAC in chlorinated hospital
water, especially hot water, with high concentrations of
organisms in shower heads (6). We did not test sufficient
numbers of samples to determine whether MAC is more
common in hospital than in residential water supplies. How-
ever, some hospitals use galvanized pipes made with zinc
alloys, and natural waters with zinc concentrations of >0.75
mg/liter are more likely to contain MAC (12). Furthermore,
continuous recirculation of hot water in hospitals may allow
mycobacteria to persist and multiply (6, 15).
Some human MAC infections may be caused by recre-
ational exposure to natural water sources or inhalation of
aerosols in the vicinity of natural bodies of water. In
addition, surface water may serve as the source of water for
municipal water supplies. In the present study, MAC was
found in numerous natural water sources and was more
likely to be isolated from streams and rivers than from
standing bodies of water. There are several possible expla-
nations for this observation. Rivers and streams collect
runoff from a wider variety of sources and may contain more
organic material or elements (e.g., zinc) conducive to the
growth of MAC. Results of studies in Finland in which
nontuberculous mycobacteria were recovered from 100% of
brook water samples indicate that low pH and high organic
content favor the isolation of mycobacteria (13).
The lower recovery rates of MAC from one set of samples
from Zaire (processed at 3 weeks) and two sets of samples
from Kenya (processed at 2 and 5 weeks, respectively) were
not explained by delays in processing. MAC isolates are
extremely hardy organisms, and the number of CFU per
milliliter in natural water sources has been demonstrated to
remain stable at 9.4 to 15.5°C and to increase by 21 log unit
at 217.8°C when samples are held for 30 days before
processing (9).
Serovars of M. avium associated with infection in patients
with AIDS were identified in M. avium isolates from water.
In parallel clinical studies in the United States, the most
common serovars infecting patients with AIDS have been
serovars 4 and 8 (11 of 23 [48%] patients) (21). These two
serovars accounted for six of eight (75%) of the environmen-
tal M. avium isolates typed in the present study. We are
unable to find previous reports of the isolation of "X"
mycobacteria from Africa. In a previous report from the
United States, "X" mycobacteria represented only 3% of
clinical MAC isolates and were found only in respiratory
specimens from recent immigrants to the United States (4).
The present findings add to other studies that we have
conducted on the epidemiology of disseminated MAC infec-
tion in patients with AIDS. Results of skin test studies with
an M. avium sensitin conducted in the United States, Fin-
land, Trinidad, and Kenya have suggested that healthy
subjects at all sites have low but comparable levels of prior
infection with MAC and that levels of prior infection are too
low to explain the high rates of disseminated MAC infection
in patients with AIDS in developed countries solely on the
basis of reactivation (23). Overall reactivity to mycobacterial
antigens is higher among healthy subjects from Kenya than
among healthy subjects from the United States and Finland.
Studies in Kenya among AIDS patients with CD4 cell counts
of <200 mm3 have confirmed a low rate of disseminated
MAC infection, and studies in Finland and the United States
have shown rates of disseminated MAC infection similar to
those presented in other published reports from developed
countries (22). The finding ofMAC isolates in environmental
water samples from all five sites examined in the present
study fits with skin test data showing similar rates of prior
infection among healthy subjects at four of the sites. Dis-
seminated MAC infection in patients with AIDS is probably
acquired late in human immunodeficiency virus disease as a
new infection. Patients in Kenya may be protected from this
infection by a combination of broad mycobacterial immu-
nity, reduced levels of exposure to environmental water as
they become ill, and the low likelihood of exposure to
MAC-infected drinking water. Patients in developed coun-
tries, on the other hand, lack broad mycobacterial immunity,
survive to a point when their CD4 cell counts may be low,
and have continued exposure to MAC-infected piped water
both at home and during hospital admissions.
ACKNOWLEDGMENTS
We thank Mildred Bergeron, Nuria Gine, Terry Kneeland, and
Carol Sox for assistance with the study; Kristin Rose for assistance
with the manuscript; and Robin Ryder for collection of water
samples in Zaire.
The present study was supported by a grant (1RO1 A130373) from
the National Institute for Allergy and Infectious Diseases.
REFERENCES
1. Bolan, G. A., A. L. Reingold, L. A. Carson, et al. 1985.
Infections with Mycobacterium chelonei in patients receiving
dialysis and using processed dialyzers. J. Infect. Dis. 152:1013-
1019.
2. Burns, D. N., R. J. Wallace, M. E. Schultz, et al. 1991.
Nosocomial outbreak of respiratory tract colonization with
Mycobacterium fortuitum: demonstration of the usefulness of
pulsed-field gel electrophoresis in an epidemiologic investiga-
tion. Am. Rev. Respir. Dis. 144:1153-1159.
VOL. 31, 1993
3230 von REYN ET AL.
3. Costrini, A. M., D. A. Mahler, W. M. Gross, J. E. Hawkins, R.
Yesner, and N. D'Esopo. 1981. Clinical and roentgenographic
features of nosocomial pulmonary disease due to Mycobacte-
rium xenopi. Am. Rev. Respir. Dis. 123:104-109.
4. Cregan, P., D. M. Yajko, V. L. Ng, et al. 1992. Use of DNA
probes to detect Mycobacterium intracellulare and "X" myco-
bacteria among clinical isolates of Mycobacterium avium com-
plex. J. Infect. Dis. 166:191-194.
5. Dawson, D. J. 1990. Infection with Mycobacterium avium
complex in Australian patients with AIDS. Med. J. Aust.
153:466-468.
6. du Moulin, G. C., K. D. Stottmeier, P. A. Pelletier, A. Y. Tsang,
and J. Hedley-White. 1988. Concentration of Mycobacterium
avium by hospital hot water systems. JAMA 260:1599-1601.
6a.Eaton, T., J. 0. Falkinham, C. F. von Reyn, R. Waddell, C. F.
Gilks, and R. J. Brindle. 1993. Abstr. Gen. Meet. Am. Soc.
Microbiol. 1993, abstr. U-79, p. 182.
7. Falkinham, J. O., III, B. C. Parker, and H. Gruft. 1980.
Epidemiology of infection by nontuberculous mycobacteria.
Am. Rev. Respir. Dis. 121:931-937.
8. George, K. L., and J. 0. Falkinham. 1986. Selective medium for
the isolation and enumeration of Mycobacterium avium-intra-
cellulare and M. scrofilacaeum. Can. J. Microbiol. 32:10-14.
9. George, K. L., B. C. Parker, H. Gruft, and J. 0. Falkinham.
1980. Epidemiology of infection by nontuberculous mycobacte-
ria. II. Growth and survival in natural waters. Am. Rev. Respir.
Dis. 122:89-94.
10. Goslee, S., and E. Wolinsky. 1976. Water as a source of
potentially pathogenic mycobacteria. Am. Rev. Respir. Dis.
113:287-292.
11. Horsburgh, C. R. 1991. Mycobacterium avium complex infec-
tion in the acquired immunodeficiency syndrome. N. Engl. J.
Med. 324:1332-1338.
12. Kirschner, R. A., B. C. Parker, and J. 0. Falkinham III. 1992.
Epidemiology of infection by nontuberculous mycobacteria:
Mycobactenium avium, Mycobacterium intracellulare, and My-
cobacterium scrofulaceum in acid, brown-water swamps of the
southeastern United States and their association with environ-
mental variables. Am. Rev. Respir. Dis. 145:271-275.
13. Iivanainen, E. K., P. J. Martikainen, P. K. Vaananen, and M. L.
Katila. 1993. Environmental factors affecting the occurrence of
mycobacteria in brook waters. Appl. Environ. Microbiol. 59:
398-404.
14. Inderlied, C. B., C. A. Kemper, and L. E. Bermudez. 1993. The
Mycobactenum avium complex. Clin. Microbiol. Rev. 6:266-
310.
15. Lockwood, W. W., C. Friedman, N. Bus, C. Pierson, and R.
Gaynes. 1989. An outbreak of Mycobacterium terrae in clinical
specimens associated with a hospital potable water supply. Am.
Rev. Respir. Dis. 140:1614-1617.
16. Lowry, P. W., W. R. Jarvis, A. D. Oberie, et al. 1988. Myco-
bacterium chelonae causing otitis media in an ear-nose-and
throat practice. N. Engl. J. Med. 319:978-982.
17. Morrissey, A. B., T. 0. Aisu, J. 0. Falkinham III, P. P. Eriki,
J. J. Ellner, and T. M. Daniel. 1992. Absence ofMycobacterium
avium complex disease in patients with AIDS in Uganda. J.
Acquired Immune Defic. Syndr. 5:477-478.
18. Nightingale, S. D., L. T. Byrd, P. M. Southern, J. D. Jockusch,
S. X. Cal, and B. A. Wynne. 1992. Mycobacterium avium-
intracellulare complex bacteremia in human immunodeficiency
virus positive patients. J. Infect. Dis. 165:1082-1085.
19. Petrini, B., A. Svahn, I. Julander, G. Kallenius, and L. Ostlund.
1991. Prevalence ofMycobacterium avium complex infection in
AIDS patients. Scand. J. Infect. Dis. 23:511-512.
20. Stanford, J. L., and R. C. Paul. 1973. A preliminary report on
some studies of environmental mycobacteria from Uganda.
Ann. Soc. Belge Med. Trop. 53:389-393.
21. von Reyn, C. F. Unpublished data.
22. von Reyn, C. F., R. D. Arbeit, C. F. Gilks, C. Bartholomew, A.
Ranki, and A. N. A. Tosteson. 1993. Risk factors for mycobac-
teremia among patients with AIDS in developed and developing
countries. IXth International Conference on AIDS. Berlin,
1993: abstract PO-B07-1186.
23. von Reyn, C. F., T. W. Barber, R. D. Arbeit, et al. 1993.
Evidence of previous infection with M. avium among healthy
subjects: An international study of dominant mycobacterial skin
test reactions. J. Infect. Dis., in press.
24. von Reyn, C. F., J. 0. Falkinham III, R. Brindle, et al. 1991. The
international epidemiology of M. avium in AIDS, abstr. W. B.
2323. VIIth International Conference on AIDS, abstr. Florence,
Italy.
J. CLIN. MICROBIOL.
